GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
2020 · Nature Communications · 290 citations
https://doi.org/10.1038/s41467-020-18020-8
S
Stanley Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
128
Papers
1.7K
Citations
15
h-index
16
i10-index
Stanley Zhou is an academic researcher from University Health Network. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Genomics and Diagnostics & RNA Research and Splicing. The author has an h-index of 15, co-authored 109 publications.
ORCID: 0000-0001-8187-0128Papers by this author
worksPioneer of prostate cancer: past, present and the future of FOXA1
2020 · Protein & Cell · 180 citations
https://doi.org/10.1007/s13238-020-00786-8
A chemical toolbox for the study of bromodomains and epigenetic signaling
2019 · Nature Communications · 122 citations
https://doi.org/10.1038/s41467-019-09672-2
Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer
2023 · Oncogene · 29 citations
https://doi.org/10.1038/s41388-023-02680-z
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
2024 · Nature Genetics · 27 citations
https://doi.org/10.1038/s41588-024-01826-3
Supplementary Tables from An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27024183.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat